Delivery Order SPE2DB24D2106-SPE2DB24FAUUE

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for use by the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract is a $46,732.08 firm fixed-price delivery order placed under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. Through this...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $4,855.35. The award, which has no set-aside designation, is issued under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. This IDC enables the DLA to fulfill recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide by issuing delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products and medical supplies to support the medical needs of the Department of Defense (DoD) healthcare facilities. The contract, valued at $92,102.40, is a firm fixed-price delivery order awarded under the DLA's SPE2DB Indefinite Delivery Contract (IDC) program, which has a total potential value of $499,999,999 and is...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. The contract, valued at up to $499,999,999, is an indefinite delivery contract (IDC) under the DLA's SPE2DB program that allows for the issuance of firm fixed-price delivery orders for a comprehensive portfolio of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides the Defense Logistics Agency (DLA) with a wide range of pharmaceutical products and medical supplies. The contract, valued at up to $57,317.20, is a firm fixed-price delivery order with no set-aside designation. The contract covers a comprehensive array of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $30,043.74 firm fixed-price delivery order under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) for the Medical Supply Chain program. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $1,786.44 firm fixed price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract. The contract is to provide the U.S. Department of Defense with a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,181.86 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract provides for the delivery of a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUUE
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. The contract, valued at up to $24,341.81, is a firm fixed-price delivery order under the DLA's larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group. This single-award IDC, known as SPE2DB, allows the DLA to issue delivery orders for a vast array of pharmaceutical items, from common medications to specialized drugs and medical supplies. Through this vehicle, DMS Pharmaceutical Group delivers both routine and critical pharmaceuticals to various DoD healthcare facilities, playing a crucial role in the federal pharmaceutical supply chain. The contract award does not include any set-aside designation.

Generated 11/25/24, 9:31 AM